- American Retirement Insider
- Posts
- ARI | 01-23-25 PM: Medicare Expansion to Cover Weight-Loss Drugs
ARI | 01-23-25 PM: Medicare Expansion to Cover Weight-Loss Drugs
Today’s Story
Former President Joe Biden's proposal to expand Medicare coverage to include GLP-1 weight-loss drugs aims to address the obesity crisis among older Americans. Currently, Medicare covers these medications only for diabetes or cardiovascular conditions. Extending coverage could benefit up to 3.4 million Medicare beneficiaries.
However, this expansion is projected to increase federal spending by approximately $35 billion from 2026 to 2034. While retirees may appreciate reduced out-of-pocket costs for these medications, the potential rise in Medicare Part D premiums and copays is a concern. As the proposal awaits approval now that Trump has taken office, retirees should stay informed about changes that could affect their healthcare expenses.
Advertisement
What Elon Musk just revealed during his latest live appearance is leaving everyone speechless. Could this announcement signal a massive shift in the tech world? Find out what Musk shared—click here to watch now.
Economic Tip
To manage potential changes in healthcare costs, consider reviewing your Medicare Part D plan annually during open enrollment periods to ensure it aligns with your medication needs and budget.